Package 16714-027-01

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16714-027-01
Digits Only 1671402701
Product NDC 16714-027
Product ID 16714-027_7d7ed052-95ae-6d58-f41f-ada9f8f97b81
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (16714-027-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2020-11-15
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "7d7ed052-95ae-6d58-f41f-ada9f8f97b81", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["4f98e9ed-f7b1-5346-af72-fccb0abf3f4b"], "manufacturer_name": ["Northstar Rx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (16714-027-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "16714-027-01", "marketing_start_date": "20201115"}], "brand_name": "Irinotecan hydrochloride", "product_id": "16714-027_7d7ed052-95ae-6d58-f41f-ada9f8f97b81", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "16714-027", "generic_name": "Irinotecan hydrochloride", "labeler_name": "Northstar Rx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA212993", "marketing_category": "ANDA", "marketing_start_date": "20201115", "listing_expiration_date": "20261231"}